Emergent Historical Balance Sheet

EBS Stock

USD 4.92 0.25 4.84%

Trend analysis of Emergent Biosolutions balance sheet accounts such as Other Current Liabilities of 68.6 M or Total Current Liabilities of 228 M provides information on Emergent Biosolutions' total assets, liabilities, and equity, which is the actual value of Emergent Biosolutions to its prevalent stockholders. By breaking down trends over time using Emergent Biosolutions balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Emergent Biosolutions latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Emergent Biosolutions is a good buy for the upcoming year.

Emergent Biosolutions Inventory

327.29 Million

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Emergent Biosolutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.

About Emergent Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Emergent Biosolutions at a specified time, usually calculated after every quarter, six months, or one year. Emergent Biosolutions Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Emergent Biosolutions and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Emergent currently owns. An asset can also be divided into two categories, current and non-current.

Emergent Biosolutions Balance Sheet Chart

At this time, Emergent Biosolutions' Other Stockholder Equity is comparatively stable compared to the past year. Short Term Debt is likely to gain to about 499.5 M in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 383.1 M in 2025.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Property Plant Equipment

Add Fundamental

Total Assets

Total assets refers to the total amount of Emergent Biosolutions assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Emergent Biosolutions books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Emergent Biosolutions balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Emergent Biosolutions are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most accounts from Emergent Biosolutions' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Emergent Biosolutions current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Emergent Biosolutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.

For more information on how to buy Emergent Stock please use our How to Invest in Emergent Biosolutions guide.At this time, Emergent Biosolutions' Other Stockholder Equity is comparatively stable compared to the past year. Short Term Debt is likely to gain to about 499.5 M in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 383.1 M in 2025.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	1.4B	860.2M	663.7M	383.1M
Total Assets	3.2B	1.8B	1.4B	1.2B

Short Long Term Debt Total Total Assets

Emergent Biosolutions balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock
Total Assets		0.93	0.51	0.62	0.94	0.72	0.67	0.45	0.6	0.73	0.74	0.54	0.44	0.73	0.62	0.63	0.75	0.57	0.62	0.77	0.71	0.96	0.64	0.38	0.69	0.64
Short Long Term Debt Total	0.93		0.54	0.77	0.75	0.68	0.84	0.29	0.62	0.59	0.76	0.69	0.35	0.59	0.56	0.71	0.65	0.59	0.71	0.74	0.63	0.99	0.63	0.61	0.77	0.75
Other Current Liab	0.51	0.54		0.62	0.37	0.78	0.4	0.55	0.89	0.44	0.78	0.67	-0.38	0.44	0.62	0.74	0.01	0.72	0.8	0.88	-0.03	0.57	0.9	0.3	0.71	0.75
Total Current Liabilities	0.62	0.77	0.62		0.44	0.71	0.61	0.38	0.62	0.51	0.69	0.9	-0.03	0.51	0.31	0.52	0.18	0.34	0.67	0.67	0.19	0.7	0.69	0.77	0.61	0.57
Total Stockholder Equity	0.94	0.75	0.37	0.44		0.68	0.4	0.54	0.45	0.81	0.59	0.33	0.49	0.81	0.53	0.41	0.75	0.41	0.43	0.68	0.71	0.81	0.55	0.18	0.48	0.42
Property Plant And Equipment Net	0.72	0.68	0.78	0.71	0.68		0.42	0.8	0.83	0.63	0.92	0.67	-0.25	0.63	0.73	0.69	0.21	0.7	0.71	0.8	0.1	0.7	0.94	0.28	0.75	0.67
Net Debt	0.67	0.84	0.4	0.61	0.4	0.42		-0.12	0.51	0.09	0.65	0.58	0.24	0.09	0.54	0.76	0.46	0.58	0.75	0.47	0.56	0.81	0.39	0.66	0.8	0.77
Retained Earnings	0.45	0.29	0.55	0.38	0.54	0.8	-0.12		0.59	0.66	0.63	0.38	-0.35	0.66	0.49	0.3	-0.02	0.45	0.21	0.56	-0.21	0.34	0.73	-0.19	0.37	0.26
Accounts Payable	0.6	0.62	0.89	0.62	0.45	0.83	0.51	0.59		0.37	0.91	0.78	-0.37	0.37	0.8	0.86	0.09	0.85	0.83	0.85	0.03	0.66	0.91	0.2	0.85	0.83
Cash	0.73	0.59	0.44	0.51	0.81	0.63	0.09	0.66	0.37		0.42	0.37	0.33	1.0	0.18	0.16	0.49	0.2	0.27	0.7	0.39	0.61	0.59	0.23	0.21	0.18
Non Current Assets Total	0.74	0.76	0.78	0.69	0.59	0.92	0.65	0.63	0.91	0.42		0.73	-0.26	0.42	0.84	0.9	0.22	0.88	0.8	0.77	0.15	0.79	0.89	0.3	0.95	0.86
Non Currrent Assets Other	0.54	0.69	0.67	0.9	0.33	0.67	0.58	0.38	0.78	0.37	0.73		-0.2	0.37	0.43	0.63	0.09	0.47	0.69	0.69	0.07	0.65	0.71	0.57	0.67	0.66
Other Assets	0.44	0.35	-0.38	-0.03	0.49	-0.25	0.24	-0.35	-0.37	0.33	-0.26	-0.2		0.33	-0.22	-0.23	0.78	-0.32	-0.14	-0.01	0.87	0.36	-0.35	0.22	-0.19	-0.17
Cash And Short Term Investments	0.73	0.59	0.44	0.51	0.81	0.63	0.09	0.66	0.37	1.0	0.42	0.37	0.33		0.18	0.16	0.49	0.2	0.27	0.7	0.39	0.61	0.59	0.23	0.21	0.18
Net Receivables	0.62	0.56	0.62	0.31	0.53	0.73	0.54	0.49	0.8	0.18	0.84	0.43	-0.22	0.18		0.85	0.31	0.89	0.68	0.59	0.2	0.64	0.7	-0.06	0.84	0.8
Good Will	0.63	0.71	0.74	0.52	0.41	0.69	0.76	0.3	0.86	0.16	0.9	0.63	-0.23	0.16	0.85		0.26	0.94	0.87	0.7	0.22	0.74	0.76	0.31	0.97	0.98
Common Stock Shares Outstanding	0.75	0.65	0.01	0.18	0.75	0.21	0.46	-0.02	0.09	0.49	0.22	0.09	0.78	0.49	0.31	0.26		0.2	0.28	0.39	0.9	0.69	0.14	0.21	0.25	0.31
Non Current Liabilities Total	0.57	0.59	0.72	0.34	0.41	0.7	0.58	0.45	0.85	0.2	0.88	0.47	-0.32	0.2	0.89	0.94	0.2		0.73	0.67	0.09	0.65	0.76	0.04	0.91	0.88
Inventory	0.62	0.71	0.8	0.67	0.43	0.71	0.75	0.21	0.83	0.27	0.8	0.69	-0.14	0.27	0.68	0.87	0.28	0.73		0.79	0.31	0.71	0.8	0.58	0.84	0.89
Other Current Assets	0.77	0.74	0.88	0.67	0.68	0.8	0.47	0.56	0.85	0.7	0.77	0.69	-0.01	0.7	0.59	0.7	0.39	0.67	0.79		0.31	0.78	0.89	0.35	0.69	0.72
Other Stockholder Equity	0.71	0.63	-0.03	0.19	0.71	0.1	0.56	-0.21	0.03	0.39	0.15	0.07	0.87	0.39	0.2	0.22	0.9	0.09	0.31	0.31		0.66	0.01	0.35	0.24	0.27
Total Liab	0.96	0.99	0.57	0.7	0.81	0.7	0.81	0.34	0.66	0.61	0.79	0.65	0.36	0.61	0.64	0.74	0.69	0.65	0.71	0.78	0.66		0.65	0.5	0.79	0.77
Total Current Assets	0.64	0.63	0.9	0.69	0.55	0.94	0.39	0.73	0.91	0.59	0.89	0.71	-0.35	0.59	0.7	0.76	0.14	0.76	0.8	0.89	0.01	0.65		0.29	0.75	0.74
Short Term Debt	0.38	0.61	0.3	0.77	0.18	0.28	0.66	-0.19	0.2	0.23	0.3	0.57	0.22	0.23	-0.06	0.31	0.21	0.04	0.58	0.35	0.35	0.5	0.29		0.36	0.4
Intangible Assets	0.69	0.77	0.71	0.61	0.48	0.75	0.8	0.37	0.85	0.21	0.95	0.67	-0.19	0.21	0.84	0.97	0.25	0.91	0.84	0.69	0.24	0.79	0.75	0.36		0.94
Common Stock	0.64	0.75	0.75	0.57	0.42	0.67	0.77	0.26	0.83	0.18	0.86	0.66	-0.17	0.18	0.8	0.98	0.31	0.88	0.89	0.72	0.27	0.77	0.74	0.4	0.94

Click cells to compare fundamentals

Emergent Biosolutions Account Relationship Matchups

Emergent Biosolutions balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	2.9B	3.0B	3.2B	1.8B	1.4B	1.2B
Short Long Term Debt Total	874.8M	841M	1.4B	860.2M	663.7M	383.1M
Total Stockholder Equity	1.4B	1.6B	1.4B	649.3M	482.8M	618.0M
Net Debt	253.5M	264.9M	763.2M	748.5M	564.2M	592.4M
Cash	621.3M	576.1M	642.6M	111.7M	99.5M	94.5M
Other Assets	65.6M	115M	57.3M	191.3M	220.0M	231.0M
Cash And Short Term Investments	621.3M	576.1M	642.6M	111.7M	99.5M	94.5M
Common Stock Shares Outstanding	53.8M	54.1M	50.1M	51.2M	53M	42.1M
Liabilities And Stockholders Equity	2.9B	3.0B	3.2B	1.8B	1.4B	1.2B
Other Current Assets	73.2M	70.4M	57.9M	47.9M	33M	26.3M
Other Stockholder Equity	745.3M	677.2M	645.8M	676.7M	700.3M	735.3M
Total Liab	1.4B	1.3B	1.8B	1.2B	906.9M	549.1M
Other Liab	199.9M	210.7M	156.8M	90.4M	104.0M	66.7M
Current Deferred Revenue	101.9M	131.5M	140.4M	26.4M	30.4M	28.1M
Long Term Debt	841M	809.4M	448.5M	446.5M	663.7M	696.9M
Property Plant And Equipment Gross	644.1M	800.1M	817.6M	794.2M	667.7M	396.8M
Accumulated Other Comprehensive Income	(25.3M)	(16.1M)	3.1M	(5.7M)	(5.2M)	(5.5M)
Property Plant Equipment	542.3M	644.1M	800.1M	817.6M	940.2M	987.3M
Retained Earnings Total Equity	421.8M	726.9M	957.8M	734M	844.1M	440.2M
Deferred Long Term Liab	63.9M	53.2M	94.9M	71.8M	82.6M	86.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Emergent Stock Analysis

When running Emergent Biosolutions' price analysis, check to measure Emergent Biosolutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Emergent Biosolutions is operating at the current time. Most of Emergent Biosolutions' value examination focuses on studying past and present price action to predict the probability of Emergent Biosolutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Emergent Biosolutions' price. Additionally, you may evaluate how the addition of Emergent Biosolutions to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Emergent Historical Balance Sheet

Emergent Biosolutions Inventory

327.29 Million

About Emergent Balance Sheet Analysis

Emergent Biosolutions Balance Sheet Chart

Total Assets

Total Current Liabilities

Emergent Biosolutions balance sheet Correlations

Emergent Biosolutions Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Emergent Biosolutions balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Emergent Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 0.99	Short Long Term Debt Total
Common Stock	+ 0.98	Good Will
Intangible Assets	+ 0.97	Good Will
Total Liab	+ 0.96	Total Assets
Intangible Assets	+ 0.95	Non Current Assets Total

Other Assets	- 0.38	Other Current Liab
Other Assets	- 0.37	Accounts Payable
Total Current Assets	- 0.35	Other Assets
Other Assets	- 0.35	Retained Earnings
Non Current Liabilities Total	- 0.32	Other Assets
Other Assets	- 0.26	Non Current Assets Total